Position in ABBV
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$31,565,193
-$1,565,857 QoQ
Shares Held
145,134
+0.1% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
15 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Employees Provident Fund Board holds $1,134,862,339 across 8 Drug Manufacturers - General names. ABBV ranks #7 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
524,361 | $482,291,516 | |
| 2 | MRK |
Merck & Co., Inc.
|
1,895,165 | $227,969,397 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
2,509,000 | $152,170,850 | |
| 4 | BIIB |
Biogen Inc.
|
704,196 | $129,100,252 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
346,000 | $48,222,020 | |
| 6 | JNJ |
Johnson & Johnson
|
182,381 | $44,581,211 | |
| 7 | ABBV |
AbbVie Inc.
This page
|
145,134 | $31,565,193 | |
| 8 | AMGN |
Amgen Inc
|
53,892 | $18,961,900 |
All Filings in ABBV
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31,565,193 | 145,134 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $33,131,050 | 145,000 | Shares | Sole | 2026-03-03 | |
| 2025-09-30 | $33,573,300 | 145,000 | Shares | Sole | 2026-03-17 | |
| 2025-06-30 | $24,138,767 | 130,044 | Shares | Sole | 2026-03-17 | |
| 2025-03-31 | $21,266,280 | 101,500 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $7,641,100 | 43,000 | Shares | Sole | 2026-03-17 | |
| 2024-09-30 | $9,874,000 | 50,000 | Shares | Sole | 2026-03-17 | |
| 2024-06-30 | $8,576,000 | 50,000 | Shares | Sole | 2026-03-18 | |
| 2024-03-31 | $8,740,800 | 48,000 | Shares | Sole | 2026-03-18 | |
| 2023-12-31 | $7,810,488 | 50,400 | Shares | Sole | 2026-03-18 | |
| 2023-09-30 | $7,303,940 | 49,000 | Shares | Sole | 2026-03-18 | |
| 2023-06-30 | $6,595,033 | 48,950 | Shares | Sole | 2026-03-31 | |
| 2020-12-31 | $3,905,617 | 36,450 | Shares | Sole | 2026-03-18 | |
| 2020-09-30 | $3,192,655 | 36,450 | Shares | Sole | 2026-03-20 | |
| 2020-06-30 | $3,808,304 | 38,789 | Shares | Sole | 2026-03-31 | |
| No filing history on record for this holder in this stock. | ||||||